Prognostic value of the MEST-C score in long-term outcomes of immunoglobulin A nephropathy patients: Insights from a developing country

doi:10.5527/wjn.v14.i4.112082

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-4)

Sum=32

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=25

Dec 25, 2025 (publication date) through Dec 23, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Nephrol. Dec 25, 2025; 14(4): 112082
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.112082

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival analysis. A: Immunoglobulin A nephropathy (IgAN) patients during follow-up stratified by MEST-C score at presentation; B: IgAN patients during follow-up, stratified by the degree of proteinuria at presentation; C: IgAN patients during follow-up, stratified by estimated glomerular filtration rate at presentation. eGFR: Estimated glomerular filtration rate.

Citation: Elahi T, Ahmed S, Mubarak M. Prognostic value of the MEST-C score in long-term outcomes of immunoglobulin A nephropathy patients: Insights from a developing country. World J Nephrol 2025; 14(4): 112082
URL: https://www.wjgnet.com/2220-6124/full/v14/i4/112082.htm
DOI: https://dx.doi.org/10.5527/wjn.v14.i4.112082